LinkedIn Icon
April 30 – May 2, 2018

Boston, MA
Earlybird Rate Closes Friday – Save $400

Partner With Us

After decades of unfulfilled potential, the commercial reality of gene therapies are beginning to take shape. However, the leading drug developer organizations in this field are telling us that they have little visibility of which contract service providers have the technical experience, capacity and flexibility to meet their demands.

Senior decision-makers at these leading companies will come together in April 2018 at Gene Therapy for Rare Disorders 2018, actively seeking to collaborate with organizations that can help them accelerate their gene therapy development.

So, who will you meet?

Spex Audience Breakdown

If you have capabilities that would benefit our audience in the gene therapy space, this meeting will provide a unique platform to showcase your solutions, generate new business leads and source opportunities for partnerships.

“This conference is a good opportunity for industry leaders to be able to come together
and learn how different companies will tackle challenges from different perspectives, 
and it allows us to learn from each other.”
Vivian Choi, Associate Director, Head of Gene Therapy Research
Shire Pharmaceuticals

Act now to stay ahead of the curve and seize the wealth of opportunity on offer.

Download the full brochure or email for more information about the partnership opportunities available which will deliver on your commercial objectives this year.